240 related articles for article (PubMed ID: 27777130)
1. ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.
De Cicco P; Panza E; Ercolano G; Armogida C; Sessa G; Pirozzi G; Cirino G; Wallace JL; Ianaro A
Pharmacol Res; 2016 Dec; 114():67-73. PubMed ID: 27777130
[TBL] [Abstract][Full Text] [Related]
2. A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury.
Campolo M; Esposito E; Ahmad A; Di Paola R; Wallace JL; Cuzzocrea S
FASEB J; 2013 Nov; 27(11):4489-99. PubMed ID: 23901068
[TBL] [Abstract][Full Text] [Related]
3. The effect of hydrogen sulfide-releasing naproxen (ATB-346) versus naproxen on formation of stress-induced gastric lesions, the regulation of systemic inflammation, hypoxia and alterations in gastric microcirculation.
Magierowski M; Magierowska K; Surmiak M; Hubalewska-Mazgaj M; Kwiecien S; Wallace JL; Brzozowski T
J Physiol Pharmacol; 2017 Oct; 68(5):749-756. PubMed ID: 29375050
[TBL] [Abstract][Full Text] [Related]
4. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
Elsheikh W; Blackler RW; Flannigan KL; Wallace JL
Nitric Oxide; 2014 Sep; 41():131-7. PubMed ID: 24747869
[TBL] [Abstract][Full Text] [Related]
5. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
Wallace JL; Caliendo G; Santagada V; Cirino G
Br J Pharmacol; 2010 Mar; 159(6):1236-46. PubMed ID: 20128814
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
Kodela R; Nath N; Chattopadhyay M; Nesbitt DE; Velázquez-Martínez CA; Kashfi K
Drug Des Devel Ther; 2015; 9():4873-82. PubMed ID: 26346117
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.
Campolo M; Esposito E; Ahmad A; Di Paola R; Paterniti I; Cordaro M; Bruschetta G; Wallace JL; Cuzzocrea S
J Neuroinflammation; 2014 Dec; 11():196. PubMed ID: 25472548
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis.
Dief AE; Mostafa DK; Sharara GM; Zeitoun TH
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1537-46. PubMed ID: 25967731
[TBL] [Abstract][Full Text] [Related]
9. Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.
Paul-Clark M; Elsheikh W; Kirkby N; Chan M; Devchand P; Agbor TA; Flannigan KL; Cheadle C; Freydin M; Ianaro A; Mitchell JA; Wallace JL
PLoS One; 2016; 11(2):e0147289. PubMed ID: 26910063
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
[TBL] [Abstract][Full Text] [Related]
11. Physiological healing of chronic gastric ulcer is not impaired by the hydrogen sulphide (H
Korbut E; Suski M; Śliwowski Z; Bakalarz D; Głowacka U; Wójcik-Grzybek D; Ginter G; Krukowska K; Brzozowski T; Magierowski M; Wallace JL; Magierowska K
Inflammopharmacology; 2024 Jun; 32(3):2049-2060. PubMed ID: 38570398
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.
Blackler RW; De Palma G; Manko A; Da Silva GJ; Flannigan KL; Bercik P; Surette MG; Buret AG; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G994-1003. PubMed ID: 25882612
[TBL] [Abstract][Full Text] [Related]
13. A comparative study on the anti-inflammatory effects of single oral doses of naproxen and its hydrogen sulfide (H2S)-releasing derivative ATB-346 in rats with carrageenan-induced synovitis.
Ekundi-Valentim E; Mesquita FP; Santos KT; de Paula MA; Florenzano J; Zanoni CI; Rodrigues L; de Nucci G; Teixeira SA; Ferreira HH; Wallace JL; Costa SK; Muscará MN
Med Gas Res; 2013 Nov; 3(1):24. PubMed ID: 24237604
[TBL] [Abstract][Full Text] [Related]
14. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
Fomenko I; Sklyarov A; Bondarchuk T; Biletska L; Panasyuk N; Wallace JL
Stress; 2014 Dec; 17(6):528-37. PubMed ID: 25238023
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids.
Costa SKPF; Muscara MN; Allain T; Dallazen J; Gonzaga L; Buret AG; Vaughan DJ; Fowler CJ; de Nucci G; Wallace JL
Antioxid Redox Signal; 2020 Nov; 33(14):1003-1009. PubMed ID: 32064887
[No Abstract] [Full Text] [Related]
16. The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine.
Mostafa DK; El Azhary NM; Nasra RA
Can J Physiol Pharmacol; 2016 Jul; 94(7):699-708. PubMed ID: 27088818
[TBL] [Abstract][Full Text] [Related]
17. Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma.
Ercolano G; De Cicco P; Frecentese F; Saccone I; Corvino A; Giordano F; Magli E; Fiorino F; Severino B; Calderone V; Citi V; Cirino G; Ianaro A
Front Pharmacol; 2019; 10():66. PubMed ID: 30800067
[TBL] [Abstract][Full Text] [Related]
18. Potent anti-inflammatory effects of an H
Glanville JRW; Jalali P; Flint JD; Patel AA; Maini AA; Wallace JL; Hosin AA; Gilroy DW
FASEB J; 2021 Oct; 35(10):e21913. PubMed ID: 34555204
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
Wallace JL; Caliendo G; Santagada V; Cirino G; Fiorucci S
Gastroenterology; 2007 Jan; 132(1):261-71. PubMed ID: 17241876
[TBL] [Abstract][Full Text] [Related]
20. The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis.
Herrera BS; Coimbra LS; da Silva AR; Teixeira SA; Costa SK; Wallace JL; Spolidorio LC; Muscara MN
Med Gas Res; 2015; 5():4. PubMed ID: 25755876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
